The bell has rung for 10 o'clock, so I welcome members, the press and the public to the Finance Committee's eighth meeting in session 2. I remind people to switch off their pagers and mobile phones. We have received no apologies from committee members.
We were not consulted in a significant way. As a chief executive in NHS Scotland, I have been involved in general discussions at meetings of chief executives with the chief executive of NHS Scotland, but I am not aware of a specific consultation.
General discussion has taken place in the chairmen's group of NHS Scotland, but a specific consultation was not held.
Paragraph 33 of the financial memorandum claims that community health partnerships can be created without additional expenditure, but I am a bit concerned about the extent to which that is possible, because many local health care co-operatives are not up to speed. Are present funds sufficient to sustain the current locality structures and to develop new structures when communities need them in addition to larger and fewer CHPs? Will the funds meet the infrastructure needs of enlarged representation on CHPs?
The structure and organisation of LHCCs is diverse between different health board areas. In some areas, significant opportunities will be presented to consolidate organisation and management arrangements upwards into community health partnerships. In some parts, opportunities are likely for financial savings on the basis of that consolidation upwards. At the same time, a strong and cohesive set of organisational and management arrangements can be created to deliver for communities what community health partnerships can do with local authorities. As that consolidation upwards will link with local authorities, I am sure that it will open a door to the better use of joint local management resources by health services and local government. Those opportunities will vary throughout Scotland.
As a health board manager, you recognise that establishing CHPs will cost money.
Yes.
How many CHPs can Argyll and Clyde afford?
We hope to form three partnerships that have co-terminous boundaries with our local authorities and two that are in partnership with Glasgow and the local authorities whose areas straddle Argyll and Clyde and Glasgow. We will need to contribute towards the cost of two partnerships with Glasgow and our local authority partners and three partnerships directly with our local authority partners. We are looking for a relationship with five partnerships in Argyll and Clyde.
How much will that cost?
We are working on the assumption that we will have to manage the cost within the costs of the seven existing LHCCs.
Health boards will be responsible not only for community health partnerships, but for public participation forums. I would be interested to hear from Neil Campbell about that, because funding for such a purpose is not currently part of a health board's remit and would be in excess of the funding for a local health care co-operative or community health partnership.
The question has been raised whether managing public consultation should be the sole responsibility of CHPs. Our policy response strongly suggests that considerable added value would be created if we used the mechanisms that have been developed for community planning, which is a statutory responsibility. That is not highlighted. We suggest that we should make those links as a matter of policy, to benefit from the advantages and to make the potential savings.
There is a parallel with the joint future agenda, which involved integrating older people's services. In our case, that was across two NHS boards and one local authority—such integration has happened throughout Scotland. That experience showed that there must be investment in development time to allow such changes to happen effectively. Although the costs of the joint future agenda were transitional, they were absorbed entirely by the partners.
I concur with the comments of colleagues in COSLA about the role of community health partnerships in public involvement and about the community planning process. As members will know, we in Argyll and Clyde became a single system on 1 July. We have been keen to avoid unnecessary duplication. We believe that community planning can play a crucial role in the development of the health service not only locally but nationally. We are keen to see whether we can work with our local authority colleagues to take advantage of some of the positive work that has been done in Scotland to involve the public. I have a local authority background and I feel that the health service can learn a lot from how local authorities have engaged with the public over many years. We are keen to explore that avenue and to cut out any unnecessary duplication.
There is a point about which I am not clear and no one is giving me an answer. Are there savings from the LHCCs that could move across into the community health partnerships? If not, how can the partnerships operate without additional resources?
It is difficult to say exactly how we will align the management arrangements in partnerships that do not yet exist. We have not received formal guidance on what the partnerships will be like or on the nature of their work. From work that we have done to develop LHCCs and from work that has been carried out over many years to develop relations with local government—through, for example, community planning—we have a good general idea of what CHPs will be like and of the kind of opportunities that they will present. However, we have not yet received any detailed guidance on the establishment of CHPs or on exactly the sort of work that they will do.
So you are saying that there will be an initial cost that might fade away over time but that you cannot quantify it.
Reform is at the core of the bill and the Scottish NHS Confederation is about to launch a major project to help to define and shape the CHPs. How will you focus on value for money, on improved effectiveness and outcomes and on avoiding exporting costs on to patients? I am thinking particularly of the delivery of services in the community—close to the patient wherever possible. How can we play a full role in energising communities and making them more attractive places for people to live in—to invest their lives in, if you will?
I will comment on that first; COSLA may want to comment after. We have good experience of working with local government, both in community planning and in joint future work. Bringing together expertise from local government and the health service creates opportunities for better cross-boundary working between professional groups. Sharing expertise and skills among work forces creates real opportunities for services and local communities. CHPs will be a vehicle for that kind of work. We have not yet been provided with the exact details of what would be expected of us, as an NHS board, in that work. However, our experience to date of working with local authorities has been positive. It has enabled the kind of integration that creates opportunities for communities and it has allowed for substantial scrutiny of cost-effectiveness and value for money.
I will pick up on a point from that and then Alexis Jay will perhaps talk about the Chartered Institute of Public Finance and Accountancy guidelines. We have to consider more than simply value for money. Added value has to be seen in improved services—not only must we be able to say that there are improved services, but the people who use the service must be able to see a direct benefit. I am not saying that that has to happen immediately; it would be naive to suggest that. Partnership working with local government and joint future work take time and a lot of continued effort. We are not just changing services; we are changing culture in the way that two fairly monolithic organisations come together to work. That will take time. We have to consider more than just value for money.
That is why my question was multifaceted. The key point was on improved effectiveness and outcomes and on the avoidance of exporting costs on to patients. The bill gives you an opportunity to be new brooms. How are you stepping up to the plate to address all the issues?
The bill represents a real challenge, but it has to be seen as an opportunity. It is a chance for us to start, right at the beginning, to work on the structure. We have to work through the guidance, get the culture right and get the key messages across. What we do has to be about partnership. We have spoken about community planning and the role of consultation. There is no point in twin-tracking things and then, at some point, saying that we need to bring them together. We should bring them together right here, right now. We should move forward collectively. That is a strong part of the COSLA response.
I absolutely concur with what has been said on cost-effectiveness. In rural areas, there is no doubt that the economy of scale that can be achieved through amalgamating LHCCs will be significant. However, as for delivery close to the ground, there is certainly a perception in Highland, where I come from and which is a very rural area—the most rural area—that services are being taken away from local areas. That is the perception among the professionals and local people.
I want to explore some of the fears expressed by Argyll and Clyde that the costs of the powers of intervention are not correctly calculated. You have said that the costs may be higher than the Executive suggests. Given the financial difficulties previously experienced by some health trusts, what would be a better estimate of the costs of those powers of intervention? I know that that is difficult to get a feeling for, as intervention would happen only under particular circumstances.
I will start and Neil Campbell will follow with more detail. This time last year, I had to approach Trevor Jones, the chief executive of NHS Scotland, and ultimately Malcolm Chisholm to ask for support because I believed that, at that point, we had a major systemic management failure in Argyll and Clyde. We can therefore comment in some detail on the cost implications of the task force that was put into Argyll and Clyde. The task force spent a couple of months in Argyll and Clyde and prepared a report that has led to our taking a series of actions to ensure that we recover the system and finances of Argyll and Clyde and consider clinical recovery and clinical redesign.
Before Neil Campbell responds, I want to mention an issue that arose in relation to the Beatson intervention, which took place to address a specific example of service failure rather than to address issues across the health board. If NHS Quality Improvement Scotland identified other service failures, could there be further demands for ministerial intervention? Would not that also be a cost within the system?
I cannot see how intervention can take place without substantial cost. I believe in intervention. Intervention is an important tool that needs to be available to the Scottish Executive Health Department in order to secure safety, quality and development of services for local communities, but it is a costly option. It requires people to be available to intervene. However, what do those people do while they are waiting to intervene? That is an issue, which must have cost implications.
That is considerably more than the estimate that is given in the financial memorandum.
There is a cost to intervention.
The dilemma for the lay observer is that, although the financial memorandum assures us that the cost implications of the reform are negligible, that is not what we have heard from the witnesses so far. How can we—and you—reassure the public that the outcome of the reforms will be a better health service? How can we reassure people that the reforms will not simply be an exercise in diverting scarce public money away from front-line health provision and into yet more health board management?
The consequence of not having the ability to intervene in an NHS system that is failing is disaster for that system, which affects not only the management or the board but front-line services—the disaster strikes the people who need those services.
Are you refuting the guidance that we have been given, which is that the cost implications are negligible?
I am taking a view, which is based on my experience in Argyll and Clyde, that intervention involves a very significant up-front and on-going cost.
We have opened up an important issue that we will need to explore with the Executive next week. Neil Campbell has highlighted that there are reservations not only about the costings that have been given for the power of intervention but about the scoping of that power. Perhaps between this week and next, the clerks could develop a line of questioning that examines the benchmarks. I am struck by the fact that we have experience of central intervention in schools. The Accounts Commission for Scotland might offer benchmarks for intervention in a single school, but that kind of intervention cannot be compared with intervention in health boards, which have budgets that run into hundreds of millions of pounds. I think that the proposal is neither scoped nor costed appropriately. It would be helpful to develop that line of questioning before we discuss the matter with the Executive next week.
First of all, I apologise to the committee for not submitting a paper earlier. The request to attend the meeting coincided with our association's annual conference last week. However, I gave a paper to the clerk this morning.
Perhaps we are straying into matters that are the subject of the submission. We are looking for a response to Wendy Alexander's question.
Okay. In paragraph 37 of the financial memorandum, it is stated that the existing financial arrangements are adequate. We believe that there are likely to be significantly increased costs for the new organisation.
If we are serious about public and patient involvement, there must be some commitment to enabling and supporting people to participate. That means investment in capacity in communities; not just in formal organisations, but in groups that represent the different interests of patients so that we avoid making the initiative tokenistic.
I hope that I understood the question about public consultation correctly. As the bill is drafted, there is an issue about accountability of CHPs; we are concerned that they would be accountable only to NHS boards. That would be an opportunity missed to examine ways in which to marry accountability with communities through local government. I recommend strongly that the committee reflect that. COSLA takes the view that we should try to ensure that, rather than be accountable only to the local health board, CHPs are accountable to more people than that board. That goes to the heart of ensuring that local government and the NHS work more closely in order to deliver better services.
You refer to what is primarily a policy, rather than financial, issue.
There will be an opportunity to benchmark. We could track significant changes that the public has been consulted on throughout Scotland. Whether that would be helpful is a matter of individual opinion. Much of what happens during consultation is discussion and provision of information. It is often a one-way process rather than a two-way process and it is not that good. It is not that intensive effort is not made and it is not that the intention is not good. Such a consultation process is not what the Finance Committee would expect of the health service and it is not what I expect as a chief executive with accountability for proper engagement with communities on major issues. Any figures that a benchmarking exercise came up with would not necessarily tell us what was effective.
I agree with everything that Neil Campbell said. I also voice my support for the comments that were made by Alexis Jay. There is a need for community capacity building. One can see from a number of consultations that have taken place the length and breadth of Scotland that some people still feel totally disenfranchised.
Our task is to find out how much the bill will cost. The financial memorandum does not say that the cost will be negligible; it says that it will be zero. However, we have learned from you that there might be far greater costs than are included in this paper.
Those are probably questions only for the representatives of the health boards.
Not really. All of our witnesses have relevant expertise; I am interested to know what proposals they have for efficiency savings that would turn money that is spent on administration into money that is spent on front-line medical services? I would also like to know whether the Executive has asked them about that.
The overall changes that will be brought about by the partnership for care system under the National Health Service Reform (Scotland) Bill are much more far-reaching than it would be simply to replace trusts with community health partnerships. In fact, trusts will not be replaced by community health partnerships at all. There will be integrated NHS systems with one board of governance and an accessible organisational arrangement with one chief executive and a tier of management under that.
Thank you. I ask for brief replies from our other witnesses because we are keeping the minister waiting.
I am not aware of the Scottish Executive's having asked us specifically about efficiency savings. There are examples of people trying to ensure that efficiency savings are made, however. In my area, for example, we would examine first-line managers of specific health and community care services, local health care co-operatives and social work teams to examine where there is overlap and duplication. Where the overlap means that it would be possible to have one manager instead of two, we will do that, to the extent that it would work best for the people involved.
I do not think that I can answer the questions that were asked.
I apologise to the witnesses for having to cut off our discussion at this stage, but I thank you all for coming to the committee today. If there are any further points that you would like to make following this discussion, we will be pleased to receive further submissions in writing.